Faculty

Institution

Unit

Venue

Daniel Igel

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

Daniel Igel is currently serving as a Neurosurgery Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Daniel Igel

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

urology oncology bladder cancer genitourinary cancers surgical oncology surgery biomedical engineering cancer care molecular cancer urological research biological engineering tissue engineering regenerative medicine nephrology outcomes research reconstructive microsurgery cancer biology regeneration (biology) tissue transplantation functional tissue engineering reconstructive urology voiding dysfunction malignant disease microbial disease antimicrobial susceptibility urinary diversion rapid prototyping additive manufacturing advanced manufacturing technologies orthopaedic research urogynecology nature biotechnology advance clinical transplantation biofabrication pain medicine gastrointestinal surgery stem cell research molecular diagnostics surgical care emergency care urogenital radiology 3d bioprinting kidney transplantation organ procurement postoperative pain management perioperative pain robot-assisted surgery soft tissue reconstruction cancer genetics dialysis therapy cancer disparities epidemiology of cancer interventional endoscopy cancer treatment prognosis prognostic biomarkers cancer management receptor tyrosine kinases tumor suppressors dysbiosis patient care immunology-based discipline tissue-engineering approaches radical cystectomy narcotic utilization compared perioperative management bladder cancer patients genotype-phenotype characterization temporal trends bladder cancer diagnosis internal validation affect endoscopic procedures objective measure multicenter study collective information

Notable Scholarly Works

Notable Federal Grants

Collaborators

Disparities and Temporal Trends in Referral for Bladder Cancer Diagnosis: A Worsening Epidemic. Urologic Oncology Seminars and Original Investigations (2025)

public healthhealth services researchbladder cancercancer caretemporal trendsbladder cancer diagnosisurologygenitourinary cancershealth systemsoncologyepidemiology of cancercancer disparities

Durability of Response of Ugn-101: Longitudinal Follow Up of Multicenter Study. Urologic Oncology Seminars and Original Investigations (2025)

Solomon L WolduDaniel IgelBrett JohnsonKatie S MurrayHiroko MiyagiWade SextonIsamu TachibanaHristos KaimakliotisJoseph JacobRian DicksteinJennifer LinehanAlan NiederMarc A BjurlinDaniel HeidenbergMitchell HumphreysSaum GhodoussipourMarcus L QuekMichael O'DonnellBrian H EisnerSurena F MatinAdam S FeldmanYair Lotan

multicenter studyurological researchoncologyurology

Genotype-Phenotype Characterization of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma. European Urology Oncology (2025)

cancer geneticsbladder cancermolecular cancermalignant diseaseurologymolecular diagnosticsgenotype-phenotype characterizationpathologyhuman genetics

Ip12-06 Expression of Nectin4 and Trop2 in Resected Upper Tract Urothelial Carcinoma With and Without Preoperative Chemotherapy. The Journal of Urology (2025)

bladder cancercancer researchmolecular cancermalignant diseaseurologygenitourinary cancersoncologyoncogenescancer treatmentcancer biologypathologytumor biology

Ip12-21 Validation of Aua Upper Tract Urothelial Carcinoma Presurgical Clinical Risk Stratification for Predicting Invasive Disease. The Journal of Urology (2025)

bladder cancercancer careradiation oncologycancer researchsurgical oncologyurologygenitourinary cancersoncologyprognostic biomarkersprognosisurological research

Ip12-27 Outcomes of Primary Chemotherapy Followed by Nephroureterectomy and Retroperitoneal Lymph Node Dissection in Patients With Clinically Node Positive Utuc. The Journal of Urology (2025)

metastasiscancer carecancer managementradiation oncologycancer researchsurgical oncologyurologygenitourinary cancersoncologykidney cancer

Ip14-08 Development and Validation of Murine Patient Derived Xenograft Models of Upper Tract Urothelial Carcinoma. The Journal of Urology (2025)

bladder cancercancer researchmolecular cancerurologygenitourinary cancersoncologykidney canceroncogenescancer biologypathologytumor biology

Ip27-37 Impact of Aurora Kinase Pathway Inhibition in Penile Squamous Cell Carcinoma Patient-Derived Xenograft Models. The Journal of Urology (2025)

cancer biologycancer researchsystems biologycell signalingmolecular cancerreceptor tyrosine kinasestumor suppressorsmolecular cell biologyoncogenescancer cellssignal transductiontumor biologycell biology

Oncologic and Survival Outcomes in Patients Undergoing Radical Nephroureterectomy With Preoperative or Iatrogenic Dialysis Dependence. Urologic Oncology Seminars and Original Investigations (2025)

surgerymedicineoutcomes researchnephrologysurgical oncologyurologydialysis therapyblood purificationgenitourinary cancersoncologykidney cancer

The Upper Tract Endometry Score: Development and Internal Validation of an Objective Measure of Variables That Affect Endoscopic Procedures for Upper Tract Urothelial Carcinoma. The Journal of Urology (2025)

surgeryaffect endoscopic proceduresbladder cancerinterventional endoscopysurgical oncologyurologygynecologic oncologygastrointestinal endoscopygenitourinary cancersurological researchgynecologic cancersoncologyobjective measuredigestive endoscopyinternal validationgynecology

1
2
10 / page

Daniel Igel

Assistant Professor

The University of Texas MD Anderson Cancer Center

Affiliations

Department Of Palliative, Rehabilitation And Integrative Medicine

Department Of Neurosurgery

Division Of Surgery

Department Of Urology

Department Of Neurosurgery

Division Of Surgery

The University of Texas MD Anderson Cancer Center

Daniel Igel is currently serving as a Neurosurgery Assistant Professor at The University of Texas Md Anderson Cancer Center.

Honors

Create free account to unlock more features

Experiences

Create free account to unlock more features

Education

Create free account to unlock more features

Daniel Igel

The University of Texas MD Anderson Cancer Center

Assistant Professor

You can click a keyword to filter the displayed items

Notable Scholarly Works

Notable Federal Grants

Collaborators

Disparities and Temporal Trends in Referral for Bladder Cancer Diagnosis: A Worsening Epidemic. Urologic Oncology Seminars and Original Investigations (2025)

public healthhealth services researchbladder cancercancer caretemporal trendsbladder cancer diagnosisurologygenitourinary cancershealth systemsoncologyepidemiology of cancercancer disparities

Durability of Response of Ugn-101: Longitudinal Follow Up of Multicenter Study. Urologic Oncology Seminars and Original Investigations (2025)

multicenter studyurological researchoncologyurology

Genotype-Phenotype Characterization of Lynch Syndrome–Associated Upper Tract Urothelial Carcinoma. European Urology Oncology (2025)

cancer geneticsbladder cancermolecular cancermalignant diseaseurologymolecular diagnosticsgenotype-phenotype characterizationpathologyhuman genetics

Ip12-06 Expression of Nectin4 and Trop2 in Resected Upper Tract Urothelial Carcinoma With and Without Preoperative Chemotherapy. The Journal of Urology (2025)

bladder cancercancer researchmolecular cancermalignant diseaseurologygenitourinary cancersoncologyoncogenescancer treatmentcancer biologypathologytumor biology

Ip12-21 Validation of Aua Upper Tract Urothelial Carcinoma Presurgical Clinical Risk Stratification for Predicting Invasive Disease. The Journal of Urology (2025)

bladder cancercancer careradiation oncologycancer researchsurgical oncologyurologygenitourinary cancersoncologyprognostic biomarkersprognosisurological research

Ip12-27 Outcomes of Primary Chemotherapy Followed by Nephroureterectomy and Retroperitoneal Lymph Node Dissection in Patients With Clinically Node Positive Utuc. The Journal of Urology (2025)

metastasiscancer carecancer managementradiation oncologycancer researchsurgical oncologyurologygenitourinary cancersoncologykidney cancer

Ip14-08 Development and Validation of Murine Patient Derived Xenograft Models of Upper Tract Urothelial Carcinoma. The Journal of Urology (2025)

bladder cancercancer researchmolecular cancerurologygenitourinary cancersoncologykidney canceroncogenescancer biologypathologytumor biology

Ip27-37 Impact of Aurora Kinase Pathway Inhibition in Penile Squamous Cell Carcinoma Patient-Derived Xenograft Models. The Journal of Urology (2025)

Oncologic and Survival Outcomes in Patients Undergoing Radical Nephroureterectomy With Preoperative or Iatrogenic Dialysis Dependence. Urologic Oncology Seminars and Original Investigations (2025)

surgerymedicineoutcomes researchnephrologysurgical oncologyurologydialysis therapyblood purificationgenitourinary cancersoncologykidney cancer

1
2
10 / page